Perez-SanJose, D.;                     de la Fuente, M.A.;                     Serna Pérez, J.;                     Simarro, M.;                     Eiros Bouza, J.M.;                     Sanz-Muñoz, I.    
        CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses? Pharmaceuticals 2022, 15, 32.
    https://doi.org/10.3390/ph15010032
    AMA Style
    
                                Perez-SanJose D,                                 de la Fuente MA,                                 Serna Pérez J,                                 Simarro M,                                 Eiros Bouza JM,                                 Sanz-Muñoz I.        
                CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses? Pharmaceuticals. 2022; 15(1):32.
        https://doi.org/10.3390/ph15010032
    
    Chicago/Turabian Style
    
                                Perez-SanJose, Diana,                                 Miguel Angel de la Fuente,                                 Julia Serna Pérez,                                 Maria Simarro,                                 José MarÃa Eiros Bouza,                                 and Ivan Sanz-Muñoz.        
                2022. "CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?" Pharmaceuticals 15, no. 1: 32.
        https://doi.org/10.3390/ph15010032
    
    APA Style
    
                                Perez-SanJose, D.,                                 de la Fuente, M. A.,                                 Serna Pérez, J.,                                 Simarro, M.,                                 Eiros Bouza, J. M.,                                 & Sanz-Muñoz, I.        
        
        (2022). CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses? Pharmaceuticals, 15(1), 32.
        https://doi.org/10.3390/ph15010032